{"transactions":[{"id":1810359,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-08-11T22:46:40.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":372000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."}],"balance_after":372000,"derivative":{"exercise_price":12.85,"expiration_date":"2025-08-10","underlying":"Common Stock","underlying_shares":372000},"source":{"system":"sec-edgar","filing":"0001628280-23-029142","document":"wk-form4_1691793990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023029142/wk-form4_1691793990.xml","form_type":"4"}},{"id":1810358,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-08-11T22:46:40.000Z","date":"2023-08-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":372000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction involves an amendment of an outstanding option, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the \"Plan\").  As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the \"Separation Date\"), 372,000 shares underlying the option, had vested (the \"Vested Options\") and the other 372,000 shares underlying the option, had not vested (the \"Unvested Options\"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date.  However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025."}],"balance_after":0,"derivative":{"exercise_price":12.85,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":372000},"source":{"system":"sec-edgar","filing":"0001628280-23-029142","document":"wk-form4_1691793990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023029142/wk-form4_1691793990.xml","form_type":"4"}},{"id":1924205,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-06T22:59:01.000Z","date":"2023-04-05","kind":"grant","planned":false,"acquired":true,"shares":117831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights."}],"balance_after":591388,"source":{"system":"sec-edgar","filing":"0001628280-23-011056","document":"wf-form4_168082192757500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023011056/wf-form4_168082192757500.xml","form_type":"4"}},{"id":1970378,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T01:41:16.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":18746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,843 shares of Class A Common Stock acquired by the reporting person under the Company's 2021 Employee Stock Purchase Plan"}],"balance_after":473557,"source":{"system":"sec-edgar","filing":"0001818093-23-000009","document":"wf-form4_167815326366015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809323000009/wf-form4_167815326366015.xml","form_type":"4"}},{"id":2409251,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T01:14:16.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":105633,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of February 4, 2022, in each case subject to continued service through the vesting date and certain acceleration rights."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of February 4, 2022, in each case subject to continued service through the vesting date and certain acceleration rights."}],"balance_after":452968,"source":{"system":"sec-edgar","filing":"0001818093-22-000029","document":"wf-form4_164436923777420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000029/wf-form4_164436923777420.xml","form_type":"4"}},{"id":2571476,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2021-09-14T23:36:32.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting."}],"balance_after":50000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001818093-21-000065","document":"wf-form4_163166257469302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809321000065/wf-form4_163166257469302.xml","form_type":"4"}},{"id":2590183,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-26T21:22:47.000Z","date":"2021-08-25","kind":"other","acquired":true,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of  December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of  December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC."}],"balance_after":347335,"source":{"system":"sec-edgar","filing":"0001818093-21-000039","document":"wf-form4_163001294258006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809321000039/wf-form4_163001294258006.xml","form_type":"4"}},{"id":2631213,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-19T23:13:53.000Z","date":"2021-07-15","kind":"other","acquired":true,"shares":77105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of  December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of  December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC."}],"balance_after":346607,"source":{"system":"sec-edgar","filing":"0001818093-21-000026","document":"wf-form4_162673640919243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809321000026/wf-form4_162673640919243.xml","form_type":"4"}},{"id":2701912,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-22T00:00:17.000Z","date":"2021-05-20","kind":"other","acquired":true,"shares":269502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported acquisition is the result of distributions for no consideration made by LCP Edge Holdco LLC to certain of its unitholders, including the reporting person, in redemption of their respective interests in LCP Edge Holdco LLC."}],"balance_after":269502,"source":{"system":"sec-edgar","filing":"0001818093-21-000013","document":"wf-form4_162164159891145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809321000013/wf-form4_162164159891145.xml","form_type":"4"}},{"id":2721870,"issuer":{"id":6863,"kind":"organization","name":"SkinHealth Systems Inc.","symbol":"SKIN"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-05-10T21:26:02.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":744000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan.  Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan.  Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date."}],"balance_after":744000,"derivative":{"exercise_price":12.85,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":744000},"source":{"system":"sec-edgar","filing":"0000899243-21-019004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818093/000089924321019004/doc4.xml","form_type":"4"}},{"id":4575583,"issuer":{"id":174754,"kind":"organization","name":"DIGILITI MONEY GROUP, INC.","symbol":"DGLT"},"owners":[{"id":110654,"kind":"person","name":"Woo Liyuan","position":1,"cik":"0001499747","reported_name":"Woo Liyuan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-24T08:54:46.000Z","date":"2016-08-17","kind":"grant","acquired":true,"shares":8000,"price":7.85,"value":62800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in three equal installments on August 17, 2016, 2017 and 2018"}],"balance_after":8000,"derivative":{"exercise_price":7.85,"expiration_date":"2021-08-17","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-16-146673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1499747/000120919116146673/doc4.xml","form_type":"4"}}]}